Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × Interferons × Clear all

NCT00678288 2014-12-11

A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.

Phase 2 Terminated

16 enrolled 6 charts

Carcinoma, Renal Cell

NCT00117637 2014-10-31

BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma

Phase 2 Completed

189 enrolled 44 charts

Carcinoma, Renal Cell, Neoplasms